{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"American Association for Cancer Research"}],"indexed":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:04:43Z","timestamp":1749873883752,"version":"3.41.0"},"posted":{"date-parts":[[2025,6,13]]},"reference-count":0,"publisher":"American Association for Cancer Research (AACR)","license":[{"start":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:00:00Z","timestamp":1749772800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:p>&lt;p&gt;Appendix&lt;\/p&gt;<\/jats:p>","DOI":"10.1158\/1078-0432.29313373","type":"posted-content","created":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:21:15Z","timestamp":1749802875000},"source":"Crossref","is-referenced-by-count":0,"title":["Supplementary Appendix S1 from Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial"],"prefix":"10.1158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1280-5909","authenticated-orcid":false,"given":"Jung-Min","family":"Lee","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9739-8462","authenticated-orcid":false,"given":"Austin","family":"Miller","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2676-0166","authenticated-orcid":false,"given":"Peter G.","family":"Rose","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8494-5591","authenticated-orcid":false,"given":"Mariam","family":"AlHilli","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-8860","authenticated-orcid":false,"given":"Christina","family":"Washington","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2688-5447","authenticated-orcid":false,"given":"Veena S.","family":"John","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0005-4372-2614","authenticated-orcid":false,"given":"Chirag A.","family":"Shah","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6232-8701","authenticated-orcid":false,"given":"Koji","family":"Matsuo","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-3634","authenticated-orcid":false,"given":"Jean","family":"Siedel","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8215-5887","authenticated-orcid":false,"given":"David S.","family":"Miller","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0577-0501","authenticated-orcid":false,"given":"Elizabeth E.","family":"Hopp","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3829-3988","authenticated-orcid":false,"given":"Andrea","family":"O\u2019Shea","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3379-6829","authenticated-orcid":false,"given":"John K.","family":"Chan","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6954-6712","authenticated-orcid":false,"given":"Leslie S.","family":"Bradford","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0155-4246","authenticated-orcid":false,"given":"Christopher B.","family":"Morse","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6454-6246","authenticated-orcid":false,"given":"Christa I.","family":"Nagel","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8884-7083","authenticated-orcid":false,"given":"Kerry J.","family":"Rodabaugh","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8631-9762","authenticated-orcid":false,"given":"Elise C.","family":"Kohn","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5803-0718","authenticated-orcid":false,"given":"Kathleen N.","family":"Moore","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3888-3972","authenticated-orcid":false,"given":"Joyce F.","family":"Liu","sequence":"first","affiliation":[]}],"member":"1086","container-title":[],"original-title":[],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T08:21:15Z","timestamp":1749802875000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacr.figshare.com\/articles\/journal_contribution\/Supplementary_Appendix_S1_from_Comparing_Durvalumab_Olaparib_and_Cediranib_Monotherapy_Combination_Therapy_or_Chemotherapy_in_Patients_with_Platinum-Resistant_Ovarian_Cancer_with_Prior_Bevacizumab_The_Phase_II_NRG-GY023_Trial\/29313373\/1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,13]]},"references-count":0,"URL":"https:\/\/doi.org\/10.1158\/1078-0432.29313373","relation":{"is-supplement-to":[{"id-type":"doi","id":"10.1158\/1078-0432.CCR-24-3877","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2025,6,13]]},"subtype":"other"}}